πŸ‡ΊπŸ‡Έ FDA

Intelligence Β· INN Directory

Pharmaceutical Drugs

Regulatory status, brand names, and pipeline context for BD, medical affairs, and competitive intelligence teams.

Drugs indexed
4,797
Companies
1,769
Pipeline programs
20,548

Quick answer

NovaPharmaNews tracks 4,797 pharmaceutical drugs by INN (International Nonproprietary Name), with US FDA approval status, brand names, originators, routes of administration, and links to pipeline programs and patents. Search by generic name or browse A–Z for competitive intelligence and medical affairs reference.

2,636 results for β€œ-” Clear

  1. lopinavir + ritonavir

    KALETRA AbbVie

    TGA: approved

  2. lorcaserin hydrochloride

    LORCASERIN HYDROCHLORIDE

    ORAL FDA: approved

  3. losartan potassium

    LOSARTAN POTASSIUM Teva Pharma GmbH

    ORAL FDA: approved

  4. loteprednol etabonate

    EYSUVIS Amneal Pharma Europe Ltd

    OPHTHALMIC FDA: approved

  5. low-dose

    NMPA: clinical trials

  6. loxapine hydrochloride

    LOXITANE C Teva Pharma GmbH

    INJECTION FDA: approved

  7. loxapine succinate

    LOXITANE ELITE PHARMACEUTICALS INC /NV/

    ORAL FDA: approved

  8. lu af28996

    NMPA: clinical trials

  9. lubricating agent

    LUBRI-GEL Lacuna Pharma Pty Ltd

    TGA: approved

  10. lucar-

    NMPA: clinical trials

  11. lumacaftor + ivacaftor

    ORKAMBI Vertex Pharmaceuticals (Australia) Pty.

    TGA: approved

  12. lumasiran sodium

    OXLUMO Alnylam Netherlands B.V.

    SUBCUTANEOUS FDA: approved

  13. lumateperone tosylate

    LUMATEPERONE TOSYLATE

    ORAL FDA: approved

  14. lurasidone hydrochloride

    LATUDA Amneal Pharma Europe Ltd

    ORAL FDA: approved

  15. luspatercept-aamt

    REBLOZYL

    SUBCUTANEOUS FDA: approved

  16. lutetium (177lu) chloride

    ENDOLUCINBETA

    EMA: approved

    V10X

  17. lutetium (177lu) oxodotreotide

    LUTATHERA

    EMA: approved

    V10XX04

  18. lutetium (177lu) vipivotide tetraxetan

    PLUVICTO

    EMA: approved

    V10XX

  19. lutetium lu 177 dotatate

    LUTATHERA

    INTRAVENOUS FDA: approved

  20. lutetium lu-177 vipivotide tetraxetan

    PLUVICTO

    INTRAVENOUS FDA: approved

  21. lutropin alfa

    LUVERIS Merck KGaA, Darmstadt, Germany

    EMA: approved Β· TGA: approved

    G03GA07

  22. ly01610 ( irinotecan hydrochloride liposome injection )

    NMPA: clinical trials

  23. ly01610 ( irinotecan hydrochloride liposome injection ) with 5-fu（fluorouracil injectionοΌ‰

    NMPA: clinical trials

  24. lysine + thiamine + pyridoxine + cyanocobalamin + ferric pyrophosphate

    ACCOMIN ADULT TONIC Pfizer Australia Pty Ltd

    TGA: approved

Frequently asked questions

What is the NovaPharmaNews drugs directory?

It is a searchable index of 4,797 pharmaceutical active ingredients and their marketed profiles β€” INN, brand names, US regulatory status, manufacturers, and cross-links to clinical pipeline and patent records.

Where does drug approval data come from?

Profiles combine FDA Drugs@FDA and Orange Book references, ClinicalTrials.gov pipeline links, and editorial enrichment. See our data sources page for attribution and update cadence. This directory is for professional reference, not medical advice.

How do I find a drug by brand name?

Use the search box on this page β€” it matches both INN (generic name) and slug. Brand names appear on each drug row and on the full drug profile page, with links to the originator company when available.

Data attribution and licensing: Data sources